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OBJECTIVES The goal of this study was to analyze left ventricular outflow tract systolic acceleration
(LVOTAcc) during alterations in left ventricular (LV) contractility and LV filling.
BACKGROUND Most indexes described to quantify LV systolic function, such as LV ejection fraction and
cardiac output, are dependent on loading conditions.
METHODS In 18 sheep (4 normal, 6 with aortic regurgitation, and 8 with old myocardial infarction),
blood flow velocities through the LVOT were recorded using conventional pulsed Doppler.
The LVOTAcc was calculated as the aortic peak velocity divided by the time to peak flow;
LVOTAcc was compared with LV maximal elastance (Em) acquired by conductance catheter
under different loading conditions, including volume and pressure overload during an acute
coronary occlusion (n  10). In addition, a clinically validated lumped-parameter numerical
model of the cardiovascular system was used to support our findings.
RESULTS Left ventricular Em and LVOTAcc decreased during ischemia (1.67  0.67 mm Hg·ml
1
before vs. 0.93  0.41 mm Hg·ml1 during acute coronary occlusion [p  0.05] and 7.9 
3.1 m·s2 before vs. 4.4 1.0 m·s2 during coronary occlusion [p 0.05], respectively). Left
ventricular outflow tract systolic acceleration showed a strong linear correlation with LV Em
(y  3.84x  1.87, r  0.85, p  0.001). Similar findings were obtained with the numerical
modeling, which demonstrated a strong correlation between predicted and actual LV Em
(predicted  0.98 [actual] 0.01, r  0.86). By analysis of variance, there was no statistically
significant difference in LVOTAcc under different loading conditions.
CONCLUSIONS For a variety of hemodynamic conditions, LVOTAcc was linearly related to the LV
contractility index LV Em and was independent of loading conditions. These findings were
consistent with numerical modeling. Thus, this Doppler index may serve as a good
noninvasive index of LV contractility. (J Am Coll Cardiol 2002;40:1320–7) © 2002 by the
American College of Cardiology Foundation
The left ventricular (LV) end-systolic pressure-volume re-
lationship, under a variety of loading conditions, has been
proposed as an index of LV contractility (1). Because the
slope of the LV end-systolic pressure-volume relationship,
LV maximal elastance (Em), is almost independent of
loading conditions, Em is one of the most reliable indexes of
LV contractility (2). However, the complexity of measuring
LV Em, requiring a pressure-volume loop recording and at
least two different hemodynamic stages, limits seriously its
clinical applicability. A load-independent, noninvasive in-
dex of LV contractility, which provides reliable results
compared with Em, would be ideal. Such a parameter may
have considerable clinical value in the diagnosis, prognosis,
and management of patients with heart disease.
Ascending aortic blood flow velocities and acceleration
have been previously reported to be sensitive to inotropic
stimulation and little affected by changes in loading condi-
tions (3,4). Accordingly, this study is aimed at analyzing
simultaneously the LV Em and the blood flow acceleration
in the left ventricular outflow tract (LVOT) under a variety
of hemodynamic conditions, including changes in preload,
afterload, and contractility.
METHODS
Preparation. Eighteen juvenile sheep were used in this
study. The study protocol was approved by the Animal Care
and Use Committee of the National Heart, Lung, and
Blood Institute. Details of anesthetic management and
surgical procedures have been previously reported (5).
Chronic aortic regurgitation had been surgically created six
months earlier in six sheep by incising the free edge of the
right coronary or the noncoronary cusp. The left anterior
descending diagonal coronary artery had been occluded six
months earlier, resulting in chronic myocardial infarction
(MI) in eight sheep. Four sheep had normal hearts.
Twenty-six weeks later, general anesthesia was induced
using intravenous pentobarbital (30 to 50 mg/kg). The
From the *Cleveland Clinic Foundation, Cleveland, Ohio; and the †National
Heart, Lung, and Blood Institute of Health, Bethesda, Maryland. Supported, in part,
by a grant of the Fe´de´ration Francaise de Cardiologie, Paris, France and grant
NCC9-60 and NCC9-58, National Aeronautics and Space Administration, Houston,
Texas.
Manuscript received November 8, 2001; revised manuscript received May 6, 2002,
accepted June 27, 2002.
Journal of the American College of Cardiology Vol. 40, No. 7, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)02138-1
sheep were intubated and ventilated. Anesthesia was main-
tained by using isoflurane with oxygen. A median sternot-
omy was performed. Left ventricular pressure was measured
by a catheter-tipped high-fidelity micromanometer (Model
SPC-350, Millar Instruments, Houston, Texas) introduced
transmurally. Another catheter-tipped micromanometer in-
troduced from the carotid artery measured ascending aortic
pressure. The catheters were interfaced with a physiologic
paper recorder (ES 2000, Gould Inc., Cleveland, Ohio).
Conductance catheter. Left ventricular pressure-volume
loops were determined by a conductance catheter (SPC 560,
Millar instruments Inc., Houston, Texas) inserted via the
LV apex. This catheter was connected to a stimulator-
microprocessor (Leycom, CardioDynamics, Zoelermeer,
the Netherlands) to display a pressure-volume signal. Elec-
tromagnetic flow probes (Model EP455, Carolina Medical
Electronics Inc., King, North Carolina) were placed around
the aorta and pulmonary artery. The conductance volume
signal was calibrated against the stroke volume derived by
the aortic electromagnetic flow probe. A snare was placed
around the inferior vena cava.
Protocol. To analyze the relationship between Em and left
ventricular outflow tract systolic acceleration (LVOTAcc),
five different hemodynamic stages were produced for each
sheep as follows. Stage 1 was baseline. Five hundred
milliliters of whole blood were then transfused over 30 min
(stage 2) in order to increase the preload. Angiotensin II was
infused to increase the afterload (stage 3), whereas nitro-
prusside was administered to decrease both preload and the
afterload (stage 4). Thereafter, the midportion of the left
anterior descending coronary artery or the proximal left
circumflex coronary artery was occluded to induce acute
regional LV ischemia (stage 5). For each stage the hemo-
dynamic state was stabilized for 15 min. Ventilation was
suspended during each measurement.
Echocardiography. Echocardiographic Doppler acquisi-
tion was performed on a Toshiba ultrasound machine
(PowerVision, Toshiba Medical System, Tokyo, Japan)
equipped with a 3.7-MHz transducer. Hearts were scanned
from the apical four-chamber window, using a standoff
between the epicardium and the surface of the probe. The
electrocardiogram was simultaneously acquired and dis-
played on the screen. The ultrasound beam was positioned
in the LVOT, parallel to the aortic flow. To limit measure-
ment errors due to a skewed peak velocity profile (6), the
sample volume was placed 1 cm below the aortic valve, in
the middle of the LVOT, where the optimal Doppler
spectrum for cardiac output is usually recorded. The LVOT
was interrogated in the pulsed-Doppler mode. Optimal
Doppler gain was adjusted to display a complete blood flow
velocity spectral envelope with minimal noise/signal ratio.
The Doppler signal was recorded on a high-fidelity video-
cassette recorder (Model SVO-9500MD, Sony, Tokyo,
Japan) interfaced with the ultrasound machine, for offline
analysis.
Mathematical modeling. Using a previously described
mathematical model of the cardiovascular system (7), the
relationship between LV Em and Doppler LVOTAcc was
also examined to verify experimental results. Briefly, our
model uses 24 first-order differential equations to simulate
pressure, volume, and flow throughout the heart and vessels,
implemented in the LabView programming environment
(National Instruments, Austin, Texas) on a 500 MHz
Pentium III based computer. This model has been previ-
ously validated clinically in described complex intracardiac
fluid dynamics and pressure-volume relationships (8,9). For
45 different permutations modeled by varying LV Em (1.0
to 7.0 mm Hg·ml1) and independently varying either
preload or afterload, instantaneous LV and LVOT pres-
sures, volumes, and velocities were derived in 5-ms intervals
for analysis. The LVOTAcc was determined from the
velocity profiles using methods similar to those previously
described for the animal data (Appendix).
Data measurements. We measured the peak positive of
the first time derivative of the left ventricular pressure
(dP/dt) (maximal dP/dt [dP/dtmax]). We determined LV
end-diastolic pressure when positive dP/dt first exceeded
200 mm Hg·ml1 and LV end-systolic pressure at the upper
point of the LV pressure curve. Aortic pressure was mea-
sured as the systolic peak and diastolic trough. Left ventric-
ular stroke volume was calculated as the flow-time integral
recorded from the aortic electromagnetic flow probe. Left
ventricular cardiac output was LV stroke volume  heart
rate.
The ventricular end-systolic pressure-volume relationship
was derived from a set of multiple and variably loaded
pressure-volume loops generated by occlusion of the inferior
vena cava. Data were digitally stored for offline analysis.
Points of LV end-systolic pressure-volume were recorded
during at least 12 loops. Data were fit by linear regression
analysis, and the calculated slope was the LV Em (Fig. 1).
Peak aortic flow velocity (PV) was measured at the point
of maximum blood flow velocity; time to peak velocity
(t-PV) was measured as the time from the onset to the peak
of the systolic velocity spectrum, and mean LVOTAcc was
the PV-to-t-PV ratio (Fig. 1). Doppler measurements of
PV, t-PV, and LVOTAcc were calculated on three consec-
utive beats and averaged.
Abbreviations and Acronyms
ANOVA  analysis of variance
EF  ejection fraction
Em  maximal elastance
LV  left ventricle/ventricular
LVOT  left ventricular outflow tract
LVOTAcc left ventricular outflow tract systolic
acceleration
MI  myocardial infarction
PV  peak aortic flow velocity
t-PV  time to peak velocity
t-PVcor  the heart rate-corrected time of time to peak
velocity
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Statistical analysis. Data are presented as mean  SD.
Changes in invasive and noninvasive parameters under
variable hemodynamic conditions were compared with the
use of an analysis of variance (ANOVA). To increase the
power of our index, we adjusted LVOTAcc for LV Em
(covariate) using an analysis of covariance. We initially
tested the linear relationship between LVOTAcc and LV Em
for each stage and in each cardiac group separately by a
least-squares method followed by a one-way ANOVA for
statistical significance. Then we investigated the homoge-
neity of regression to detect an interaction. For p 0.05, we
accepted the homogeneity of slopes, and a standard one-way
covariance was indicated. For the overall study, correlation
between LVOTAcc and Em were investigated by linear
regression analysis. A p value of0.05 was considered to be
significant. To determine the intra- and interobserver vari-
ability for the LVOTAcc and for the LV Em measurements,
12 random data set were analyzed by one observer on two
different days and by two independent observers.
RESULTS
LV systolic and diastolic function at baseline. At base-
line, the three groups had similar heart rates and mean
aortic pressures (Table 1). Left ventricular ejection fractions
(EFs) were significantly lower in animals with chronic MI
than those with aortic regurgitation or normal hearts. The
aortic regurgitation group had higher cardiac outputs than
the other groups. Left ventricular peak dP/dt was signif-
icantly smaller in animals with chronic MI than the other
groups. Left ventricular Em was significantly lower in
animals with chronic MI and aortic regurgitation than in
normal sheep.
Effects of hemodynamic conditions on Em, PV, t-PV,
and LVOTAcc. The effects of alterations in loading condi-
tions and LV contractility on LVOTAcc and LV Em are
shown in Table 2. Hemodynamic studies were successful in
91% of the stages. The study could not be completed in
eight sheep of 18 due to fatal ventricular fibrillation or
bradyarrhythmia during the acute coronary occlusion.
Changes in loading conditions did not affect LV Em
significantly. However, LV Em was significantly decreased
during acute ischemia as compared with the other stages (p
 0.05).
Left ventricular outflow tract peak velocity was 63  13
cm·s1. Peak velocity tended to be higher during blood
infusion (68  15 cm·s1, p  NS) and angiotensin II
infusion (67  17 cm·s1, p  NS) and lower during
nitroprusside infusion (59  11 cm·s1, p  NS). Peak
velocity was significantly decreased during acute coronary
occlusion (44  9 cm·s1, p  0.05). Time to peak velocity
was 91 36 ms at baseline. Time to peak velocity decreased
to 83  31 ms and 79  28 ms during angiotensin II
infusion and nitroprusside infusion, respectively, and in-
creased to 100  21 ms during LV ischemia.
The LVOTAcc was insensitive to both preload and
afterload alteration. However, LVOTAcc showed a tendency
Figure 1. An example of left ventricular (LV) pressure-volume relationship recording from an invasive conductance catheter (left) and LV outflow tract
pulsed-wave Doppler recording from the apical view. Left ventricular outflow tract acceleration was calculated as peak velocity  time to peak velocity
(right).
Table 1. Heart Rate, Aortic Pressure, and Left Ventricular
Function
Normal
(n  4)
Old MI
(n  8)
Aortic
Regurgitation
(n  6)
General Data
HR (beats/min1) 109  15 93  18* 100  8
MAP (mm Hg) 79  31 84  19 87  17
Systolic Function
LV EF (%) 60  9 29  14* 68  10†
LV ESP (mm Hg) 87  34 94  18 99  19
LV peak  dP/dt
(mm Hgs1)
1,346  478 842  191* 1,170  409
LV Em (mm Hgml
1) 2.71  0.35 1.37  0.47* 1.39  0.20*
Cardiac output (lmin1) 2.0  0.3 1.8  0.2 4.2  0.7*†
Analysis of variance: *p  0.05 as compared with normal sheep; †p  0.05 as
compared with old MI.
EF  ejection fraction; Em  maximal elastance; ESP  end-systolic pressure;
HR  heart rate; LV  left ventricle; MAP  mean aortic pressure; MI 
myocardial infarction
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to be higher during angiotensin II infusion. There was a
definite change in the LVOTAcc after acute coronary
occlusion as compared with the other stages (p  0.05).
When a one-way analysis of covariance was performed, we
did not detect any statistical difference between LVOTAcc
and LV Em in the four different stages (p  0.06),
indicating that LVOTAcc was load-independent. However,
statistical significance was attained for the three different
groups (p  0.002), confirming that LVOTAcc was influ-
enced by different cardiac diseases.
Correlation between LVOTAcc and Em. An example of
LVOTAcc and LV Em under different hemodynamic con-
ditions is shown in Figure 2. The LVOTAcc was linearly
related to LV Em (y  3.84x  1.87, r  0.85, p  0.001)
(Fig. 3).
The LVOTAcc was calculated from the equation:
LVOTAcc  PV/t-PV. Because t-PV was significantly pro-
longed during acute coronary occlusion, we calculated the
corrected t-PV (the heart rate-corrected time of time to peak
velocity [t-PVcor]), obtained by dividing t-PV by the square
root of the RR interval (10). The corrected LVOTAcc was then
calculated as the ratio of PV/t-PVcor. The correlation between
measured LV Em and LVOTAcc corrected for the heart rate
was good (y  8.2x  6.3, r  0.84, p  0.001).
Model of LVOTAcc. For the 45 conditions simulated,
LVOTAcc ranged from 4.6 to 28.5 cms
2. Similar to the
animal data, there was a strong linear relationship between
modeled Em and LVOTAcc (LVOTAcc  3.91[LV Em] 
2.25; r 0.94, p 0.001). Furthermore, when the equation
relating Em to LVOTAcc was used to predict Em from the
animal LVOTAcc measurements, a linear relationship was
observed between the observed and expected Em (LV Em
expected  0.98, LV Em observed 0.01, r  0.86, p 
0.001) (Fig. 4).
Intraobserver and interobserver variability. A good
agreement was found when LVOTAcc and LV Em were
measured by the same observer (r 0.93, mean difference
0.21  1.16 cm·s2, r  0.94, mean difference  0.23 
0.25 mm Hg·ml1, respectively). There was a good agree-
ment between the two independent observers’ measure-
ments for LVOTAcc and for the LV Em (r  0.89, mean
difference  0.03  1.43 cm·s2, r  0.95, mean difference
 0.001  0.42 mm Hg·ml1, respectively).
DISCUSSION
This study demonstrates that LVOTAcc, an index of LV
contractility independent of loading conditions, predicted
alterations in LV systolic function, whereas conventional
parameters failed to detect LV systolic impairment.
Previous studies about LV Em. A major limitation in
assessing LV systolic function is the load-dependence of
cardiac output, peak positive dP/dt, and EF. In the late
1970s, Sagawa et al. (1) described the LV end-systolic
pressure-volume relationship over a wide range of end-
systolic points, demonstrating that the slope of the end-
systolic pressure-volume relationship (LV Em) was linear,
relatively insensitive to cardiac loading, and varied signifi-
cantly in response to change in LV contractility. Therefore,
LV Em was considered to be the most reliable index of LV
contractility. However, this index can be only obtained
using sophisticated invasive procedures, including a
pressure-volume catheter along with an abrupt change in
preload or afterload. Therefore, its clinical use is limited.
Being aware of the advantages of measuring LV Em,
several authors attempted to simplify its calculation. The
simplest method, reported by Little (11), was to calculate
the ratio of end-systolic pressure to end-systolic volume.
This simplified equation assumes constant zero pressure and
volume intercepts. This is problematic because for a similar
LV end-systolic pressure and volume ratio the volume
intercept varies depending on the cardiac abnormality (12).
Another approach was to calculate LV Em as LV peak
isovolumetric pressure  end-systolic pressure  LV stroke
volume. Igarashi et al. (13) and Takeuchi et al. (14)
validated this method in normal hearts using the actual or
an estimated LV peak isovolumetric pressure. However,
when applied to a variety of cardiac abnormalities, the
correlation between actual LV Em and estimated LV Em
was weak because the cosine function-derived LV peak
isovolumetric pressure was not applicable to dilated hearts
(15). The last simplified method to calculate LV Em was
Table 2. Blood Flow Velocity, Time to Peak Flow, Acceleration and Left Ventricular Maximal
Elastance Under a Variety of Hemodynamic Conditions
Baseline
(n  18)
Inf.
(n  18)
Angio.
(n  18)
Nitro.
(n  18)
Acute Cor. Occ.
(n  10)
HR (beats/min1) 99  13 108  17 101  12 102  16 85  11*†‡§
MAP (mm Hg) 84  20 108  18* 129  17*† 67  17*†‡ 71  21†‡
LV EDP 9  3 11  4 12  4* 9  4‡ 17  6*†‡§
LV Em (mm Hgml
1) 1.67  0.67 1.47  0.68 1.86  0.67 1.50  0.58 0.93  0.41*†‡§
PV (cm/s) 63  13 68  15 67  17 59  11† 44  9*†‡§
t-PV (ms) 91  36 92  32 83  31 79  28 100  21
LVOTAcc (ms
2) 7.9  3.1 8.2  3.1 8.7  2.6 8.2  2.7 4.4  1.0*†‡§
Analysis of variance: *p  0.05 as compared with baseline; †p  0.05 as compared with infusion; ‡p  0.05 as compared with
angiotensin; §p  0.05 as compared with nitroprusside.
Angio.  angiotensin infusion; Cor. Occ.  coronary occlusion; HR  heart rate; Inf.  blood infusion; EDP 
end-diastolic pressure; Em  maximal elastance; LV  left ventricular; LVOTAcc  left ventricular outflow tract blood flow
acceleration; MAP  mean aortic pressure; Nitro.  nitroprusside infusion; PV  peak velocity; t-PV  time to peak velocity.
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described by Senzaki et al (15). During early contraction the
normalized time-varying elastance curve of the LV is similar
among several underlying cardiac abnormalities and can be
integrated in a complex equation in combination with LV
end-systolic volume, LV end-diastolic volume, and aortic
pressure to determine LV Em. However, despite rigorous
efforts to simplify LV Em measurement, no individual
method is applicable to all cardiac conditions and free of
complicating factors or invasive procedure. Therefore, they
have not seen widespread use in routine clinical settings.
Aortic blood flow acceleration. Despite some limitations,
Doppler ultrasound recording of blood flow velocity, in the
LVOT, ascending aorta, or descending aorta is well-
validated to measure and to detect changes in cardiac output
(16,17). Additional information such as peak velocity and
acceleration can be obtained from aortic blood flow velocity.
Noble et al. (18) first described and demonstrated invasively
using a catheter-tipped velocity probe that the maximal
acceleration of blood into the ascending aorta was sensitive
to inotropic state and relatively insensitive to the loading
conditions of the heart. Similar results were reported by
Bennett et al. (3) using noninvasive Doppler ultrasound
measurement of the ascending blood flow velocities in
normals and later by Mehta et al. (19) in patients with
chronic MIs. A limitation of measuring the maximal accel-
eration of the blood flow velocity is the need to calculate the
first differential of velocity. This cannot be done routinely.
Because a good correlation exists between peak and mean
aortic blood flow acceleration (20), Wallmeyer et al. (4)
calculated the mean acceleration of the ascending aortic
blood flow velocity as the ratio of PV to t-PV flow. They
reported that ascending aortic blood flow mean acceleration
Figure 2. An example of left ventricular pressure-volume relationship (top), left ventricular outflow tract (LVOT) velocity (middle), and hemodynamic flow
velocity data with numerical simulation modeling (bottom) for a sheep with chronic myocardial infarction at baseline, after blood infusion, after angiotensin
infusion, after nitroprusside infusion, and during acute coronary occlusion.
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was significantly affected by inotropic alteration in dogs.
Furthermore, Singer et al. (21) established that aortic blood
flow mean acceleration was variably affected by alterations in
loading condition.
In the present study, the forward blood flow mean
acceleration was measured in a new location, that is, the
LVOT. Consistent changes were seen in the Doppler-
determined LVOT blood flow mean acceleration with
changing LV contractility. However, despite a tendency for
the Doppler LVOT blood flow mean acceleration to be
higher during blood infusion, angiotensin infusion, and
nitroprusside infusion, it was not significantly so. In addi-
tion, because there was a linear relationship between LV Em
and LVOT blood flow mean acceleration, LVOT blood
flow mean acceleration can be used as a surrogate for LV
Em. Further validation of our experimental results was
obtained through the numerical simulation of a wide range
of physiologic conditions, which confirmed the linear rela-
tionship between the LV Em and LVOTAcc. Doppler-
determined LVOT blood flow mean acceleration also re-
flects acute and chronic changes in the LV contractility.
Interestingly, in animals with aortic regurgitation, LV
systolic dysfunction was present as indicated by both lower
LV Em and lower LVOT blood flow mean acceleration
despite good LV EF and cardiac output. Sabbah et al. (22)
reported a close correlation between the ascending blood
flow maximal acceleration and the LV EF. However, they
did not explore this index in animals with potential LV
dysfunction and normal LV EF such as found with aortic
regurgitation or high-output heart failure.
Study limitations. The most important technical problem
encountered in measuring the LVOTAcc is difficulty in
correctly identifying the onset and the peak of the blood
flow velocity spectrum. Due to this technical limitation,
Wallmeyer et al. (4) reported an LVOTAcc mean difference
between observers of 16.8%. As a second limitation, LVO-
TAcc was not tested in the presence of turbulent flow in the
outflow tract. It is unlikely that LVOTAcc is applicable in
patients with aortic stenosis or other types of LVOT
obstruction. A third limitation relates to the velocity profile
in the LVOT. In the present study, blood flow velocities
were interrogated in the center of the LVOT. However,
from previous studies we know that the blood flow velocity
profile is skewed (6). The highest blood flow velocities are
Figure 3. Comparison between left ventricular (LV) outflow tract acceleration (LVOTAcc) (y axis) calculated from peak aortic flow velocity/time to peak
velocity and LV maximal elastance (Em) from pressure-volume loops (x-axis) in 82 hemodynamic conditions. Solid triangles  during change in loading
conditions; open triangles  during acute coronary occlusion.
Figure 4. Comparison between left ventricular (LV) maximal elastance (Em) calculated from predicted LV outflow tract systolic acceleration (y axis) and
actual pressure-volume loops (x axis) in 82 hemodynamic conditions.
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recorded near the septum and the anterior wall. As a direct
function of velocity, LVOT mean acceleration should be
affected by the site of blood flow interrogation, leading to a
different relationship between LVOTAcc and LV Em. For
consistency, reproducibility, and repeatability, care must be
taken to measure LVOTAcc at the same location. By
extension, blood flow velocities are also affected by age.
However, because the time to peak flow has not been
explored in the elderly, age effects on LVOTAcc are un-
known.
Clinical implications. The LVOTAcc reflects the LV con-
tractility represented by LV Em. It has numerous advantages
over the measurement of the LV pressure-volume relation-
ship. It is noninvasive and easily and quickly measurable. It
may be preferred when LV EF and cardiac output fail to
detect LV dysfunction such as in patients with aortic
regurgitation or high-output heart failure. In contrast with
studies by Bennett et al. (23), which demonstrated a close
relationship between aortic peak flow acceleration and EF in
patients with ischemic heart disease, we found a weak
correlation between these two parameters (r  0.43).
Similarly, cardiac output was not related to LVOTAcc (r 
0.35). However, we found a good correlation between
LVOTAcc and LV dP/dt, another index of LV systolic
function (r  0.62).
Measuring the time-course of LVOTAcc could be infor-
mative for surgical and medical decision-making. To date,
LV EF is one of the most employed parameters used to
follow patients with heart disease. However, it is well
known that LV EF is dependent on loading conditions.
Therefore, LVOTAcc, which was independent of loading
conditions, could be used to detect LV dysfunction in order
to initiate therapy and to make serial evaluations of LV
function after therapeutic interventions. Last, correlating
LVOTAcc and the prognosis of disease would certainly be a
useful application.
Conclusions. Under varied cardiac conditions, LVOTAcc
was linearly related to LV Em, reflected acute and chronic
changes in LV Em, and was independent of loading condi-
tions. Thus, this Doppler-determined index may serve as a
good noninvasive index of LV contractility.
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APPENDIX
Numerical modeling was based upon previous research
describing the mathematical relationships of fluid propaga-
tion through the cardiac chambers during both systole and
diastole. In the LabView (National Instruments, Austin,
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Texas) programming environment we used, the lumped
parameter, closed-loop model consisted of 24 first-order
differential equations. These iteratively solved equations
yield instantaneous (5-ms intervals) pressures (Equation 1),
volumes (Equation 2), and flows (Equation 3) through the
cardiovascular system (four chambers, pulmonary and sys-
temic arterial and venous systems) across each of the four
valves. A linear pressure-volume relationship and a constant
compliance is used for the atrial, pulmonary, and systemic
systems; for the ventricles, a linear pressure-volume rela-
tionship was used for systole, whereas diastole was modeled
with a rising monoexponential function above and a nega-
tive exponential equation below an equilibrium volume.
Experimentally obtained and clinically verified values for left
atrial and ventricular systolic and diastolic parameters were
used as constants (7). Results of the derived left ventricular
hemodynamic data are summarized below.
dPi
dt

(Qi1/2Qi1/2)
Ci
[1]
dV
dt
 Qin Qout [2]
dQj
dt

Pj1/2 Pj1/2 rj (Qj)
mj
[3]
C  compliance; i  chamber node; j  flow node; m 
inertial term; P  pressure; Q  flow; r  resistance term;
t  time; V  volume (ml).
Summary of Simulation Data of Hemodynamic Parameters
Min Max Ave SD
LV end-systolic elastance 1.00 7.00
Systemic pressures (mm Hg)
Mean 35.27 143.63 75.58 24.23
Systolic 43.41 161.50 90.99 26.73
Diastolic 27.56 123.68 59.81 21.45
LV EDP (mm Hg) 4.59 41.48 17.69 8.06
LV stiffness (mm Hg/ml) 0.21 1.27 0.52 0.24
End-diastolic volume (ml) 73.81 153.77 114.27 20.26
Stroke volume (ml) 32.67 93.97 66.20 15.56
Ejection fraction 0.34 0.75 0.58 0.11
LVOTAcc (cm/s
2) 4.01 28.50 16.59 7.94
Ave  average; EDP  end-diastolic pressure; LV  left ventricular; LVOTAcc 
left ventricular outflow tract systolic acceleration.
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